NAICS 325411Medicinal and Botanical Manufacturing

The Census Bureau's definition, the SBA size standard that decides who is small under it, and the federal market behind it: what the government spends under 325411, the agencies that buy it, the companies that win it and the notices open under it today.

$20.3B

Federal contract obligations

FY 2022 to FY 2027 so far

100%

Top buying department

Department of War

0.9%

To small businesses

Share of the obligations

1

Open notices now

SAM.gov, posted under this code

Official definition

Census Bureau, 2022 NAICS, verbatim.

This U.S. industry comprises establishments primarily engaged in (1) manufacturing uncompounded medicinal chemicals and their derivatives (i.e., generally for use by pharmaceutical preparation manufacturers) and/or (2) grading, grinding, and milling uncompounded botanicals.

Illustrative activities (60)

  • Acetylsalicylic acid manufacturing
  • Adrenal derivatives, uncompounded, manufacturing
  • Agar-agar manufacturing
  • Amphetamines, uncompounded, manufacturing
  • Anesthetics, uncompounded, manufacturing
  • Antibiotics, uncompounded, manufacturing
  • Anticholinergics, uncompounded, manufacturing
  • Anticonvulsants, uncompounded, manufacturing
  • Antidepressants, uncompounded, manufacturing
  • Ascorbic acid (i.e., vitamin C), uncompounded, manufacturing
  • Atropine and derivatives manufacturing
  • Barbiturates, uncompounded, manufacturing
  • Barbituric acid manufacturing
  • Brucine manufacturing
  • Caffeine and derivatives (i.e., basic chemicals) manufacturing
  • Cephalosporin, uncompounded, manufacturing
  • Cinchona and derivatives (i.e., basic chemicals) manufacturing
  • Cocaine and derivatives (i.e., basic chemicals) manufacturing
  • Codeine and derivatives (i.e., basic chemicals) manufacturing
  • Cod liver oil, medicinal, uncompounded, manufacturing
  • Concentrated medicinal chemicals, uncompounded, manufacturing
  • Cortisone, uncompounded, manufacturing
  • Dietary supplements, uncompounded, manufacturing
  • Digitoxin, uncompounded, manufacturing
  • Endocrine products, uncompounded, manufacturing
  • Enzyme proteins (i.e., basic synthetic chemicals), pharmaceutical use, manufacturing
  • Ephedrine and derivatives (i.e., basic chemicals) manufacturing
  • Ergot alkaloids (i.e., basic chemicals) manufacturing
  • Fish liver oils, medicinal, uncompounded, manufacturing
  • Glandular derivatives, uncompounded, manufacturing
  • Glycosides, uncompounded, manufacturing
  • Grinding and milling botanicals (i.e., for medicinal or dietary supplement use)
  • Herbal supplements, uncompounded, manufacturing
  • Hormones and derivatives, uncompounded, manufacturing
  • Hypnotic drugs, uncompounded, manufacturing
  • Insulin, uncompounded, manufacturing
  • Magnesia, medicinal, uncompounded, manufacturing
  • Medicinal chemicals, uncompounded, manufacturing
  • Medicinal gelatins manufacturing
  • Morphine and derivatives (i.e., basic chemicals) manufacturing
  • Nicotine and derivatives (i.e., basic chemicals) manufacturing
  • N-methylpiperazine manufacturing
  • Oils, vegetable and animal, medicinal, uncompounded, manufacturing
  • Ophthalmic agents, uncompounded, manufacturing
  • Opium and opium derivatives (i.e., basic chemicals) manufacturing
  • Penicillin, uncompounded, manufacturing
  • Physostigmine and derivatives (i.e., basic chemicals) manufacturing
  • Pituitary gland derivatives, uncompounded, manufacturing
  • Procaine and derivatives (i.e., basic chemicals) manufacturing
  • Quinine and derivatives (i.e., basic chemicals) manufacturing
  • Reserpines (i.e., basic chemicals) manufacturing
  • Salicylic acid, medicinal, uncompounded, manufacturing
  • Steroids, uncompounded, manufacturing
  • Strychnine and derivatives (i.e., basic chemicals) manufacturing
  • Sulfa drugs, uncompounded, manufacturing
  • Sulfonamides, uncompounded, manufacturing
  • Tetracycline, uncompounded, manufacturing
  • Theobromine and derivatives (i.e., basic chemicals) manufacturing
  • Vegetable alkaloids (i.e., basic chemicals) (e.g., caffeine, codeine, morphine, nicotine), manufacturing
  • Vitamins, uncompounded, manufacturing

What the manual classifies elsewhere

  • Manufacturing packaged compounded medicinals and botanicals--are classified in U.S. Industry 325412, Pharmaceutical Preparation Manufacturing; and325412
  • Manufacturing vaccines, toxoids, blood fractions, and culture media of plant or animal origin (except for diagnostic use)--are classified in U.S. Industry 325414, Biological Product (except Diagnostic) Manufacturing.325414

Small business size standard

SBA's rule under 13 C.F.R. 121.201, a different authority from the classification.

1,000 employees

In force today. 13 C.F.R. 121.201

SBA proposes2,350 employeesRaised 2.4x

Proposed rule, 91 FR 53741 (Aug 20, 2026). Comments closed Nov 20, 2026. Not in force until SBA publishes a final rule.

Read the comments on Regulations.gov

Docket SBA-2026-0199

SBA OHA appeals that cite it

NAICS designation and size appeals whose caption or digest states this code. OHA dockets by case number rather than by industry, so this is a text match on the published text, not a field the corpus stores.

No OHA decision in the corpus names this code.

The market under 325411

Who buys it, who wins it

Prime contract obligations under 325411, FY 2022 to FY 2027 so far, live from USAspending.gov. Companies are summed across their registrations.

Obligations by fiscal year

$20.3B
Total, FY 2022 to FY 2027 so far
-9.8%
FY 2026 vs FY 2025
0
$2B
$4B
$6B
FY 2022
$3.4B
FY22
FY 2023
$3.3B
FY23
FY 2024
$4.2B
FY24
FY 2025
$5.0B
$5.0B
FY25
FY 2026
$4.5B
$4.5B
FY26
FY 2027 to date
$16K
$16K
FY27*

* FY 2027 to date: the fiscal year still running.

Obligations by fiscal year
FY 2022$3.4B
FY 2023$3.3B
FY 2024$4.2B
FY 2025$5.0B
FY 2026$4.5B
FY 2027 to date$16K

Agencies that buy it

  1. Defense Logistics Agency
    $20.2B
  2. Department of the Army
    $64.9M
  3. Bureau of Land Management
    $14.6M
  4. Department of State
    $14.6M
  5. National Institutes of Health
    1 open under 325411
    $4.3M
  6. Centers for Disease Control and Prevention
    $2.3M
  7. Department of Veterans Affairs
    $1.5M
  8. Animal and Plant Health Inspection Service
    $250K

Who wins it

  1. AMERISOURCEBERGEN DRUG CORP
    $16.5B
  2. MCKESSON CORPORATION
    $3.5B
  3. DMS PHARMACEUTICAL GROUP INC
    $147.5M
  4. EMERGENT BIODEFENSE OPERATIONS LANSING LLC
    $63.3M
  5. CARDINAL HEALTH, INC.
    $26.3M
  6. MERIDIAN MEDICAL TECHNOLOGIES, LLC
    $21.4M
  7. ANIMAL HEALTH INTERNATIONAL, INC.
    $14.6M
  8. FRESENIUS KABI, LLC
    $9.1M
  9. PHOENIX TEXTILE CORPORATION
    $9.1M
  10. ATLANTIC DIVING SUPPLY, INC.
    $4.8M

What is bought under it

Product and service codes (PSC) on the awards under this industry.

  1. 6505DRUGS AND BIOLOGICALS
    $19.9B
  2. 6515MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES
    $362.4M
  3. 6509DRUGS AND BIOLOGICALS, VETERINARY USE
    $14.6M
  4. AN11HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH
    $4.0M
  5. R799SUPPORT- MANAGEMENT: OTHER
    $2.1M
  6. G006SOCIAL- GOVERNMENT LIFE INSURANCE PROGRAMS
    $612K
  7. 6510SURGICAL DRESSING MATERIALS
    $562K
  8. 6525IMAGING EQUIPMENT AND SUPPLIES: MEDICAL, DENTAL, VETERINARY
    $454K
  9. 6550IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
    $329K
  10. 6810CHEMICALS
    $289K

The largest awards under 325411

Award value to date, from USAspending.gov. Each award opens on USAspending.gov.

The largest awards could not be read from USAspending.gov just now. Open the code in the dashboard for a live read.

Open notices under 325411

SAM.govContract Opportunities, refreshed daily. Each notice opens on SAM.gov.

1 open1 due within 30 daysNo set aside 1

Search every award under 325411

Filter the prime awards by keyword, agency, company, set-aside, place of performance and fiscal-year window, and download the list.

Every open notice, filtered

All open SAM.gov notices under the code by set-aside, notice type and agency, searchable by keyword.

Where you stand under 325411

Your own awards under the code, your size under its standard, and the open notices matched to your company.

Related industries

FAQ

NAICS 325411,
answered.

The size standard, the spending and the buyers under Medicinal and Botanical Manufacturing, from the figures on this page.

NAICS 325411 is Medicinal and Botanical Manufacturing in the 2022 North American Industry Classification System. This U.S. industry comprises establishments primarily engaged in (1) manufacturing uncompounded medicinal chemicals and their derivatives (i.e., generally for use by pharmaceutical preparation manufacturers) and/or (2) grading, grinding, and milling uncompounded botanicals.

The SBA size standard for NAICS 325411 is 1,000 employees under 13 C.F.R. 121.201. SBA has proposed 2,350 employees in 91 FR 53741; the proposal is not in force until SBA publishes a final rule.

Federal agencies obligated $20.3B in prime contracts under NAICS 325411 over FY 2022 to FY 2027 so far, including $4.5B in fiscal year 2026, according to USAspending.gov.

The agencies that obligated the most under NAICS 325411 over FY 2022 to FY 2027 so far are Defense Logistics Agency, Department of the Army and Bureau of Land Management, according to USAspending.gov.

The companies that won the most prime contract dollars under NAICS 325411 over FY 2022 to FY 2027 so far are AMERISOURCEBERGEN DRUG CORP, MCKESSON CORPORATION and DMS PHARMACEUTICAL GROUP INC, according to USAspending.gov.

Work the market under 325411

Rank the buyers and the partners under this code, search its awards and notices, and see where your company stands. Monthly Pro starts with a 14-day free trial.

Sources: U.S. Census Bureau, 2022 NAICS; 13 C.F.R. 121.201; USAspending.gov; SAM.gov Contract Opportunities; SBA Office of Hearings and Appeals. Figures refresh daily. A code and a size standard shown here are research, not a size determination or a NAICS code designation, which only SBA and the contracting officer make. A company or agency listed here is not an endorsement.